MEDAYLA Canadian Trademark Information

Pharmaceutical preparations for treating central nervous system diseases or disorders Pharmaceutical preparations for treating central nervous system diseases and disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking habits or addictions, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse or respiratory system diseases or disorders, Parkinson's Disease OFF (Hypomobility) episodes and binge eating disorders; pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; Pharmaceutical preparations for the treatment of Parkinson's Disease; Therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease Pharmaceutical preparations for treating central nervous sys...

Perfect for these industries

Pharmaceutical Products

Words that describe this mark

pharmaceutical preparations treating central nervous diseases disorders pharmaceutical preparations treating central nervous diseases disorders central nervous infections brain diseases central nervous movement disorders ocular mobility disorders spinal cord diseases encephalitis

Abandonment Notice! On Wednesday, October 23, 2019, status on the MEDAYLA trademark changed to Interruption of proceeding. Apply Now for this name starting at $449!

CAUTION: Although Canada registration for this particular filing is inactive, the mark may still enjoy common law rights, or may have been applied for again in a separate application. Further research may be warranted to determine where this mark is truly abandoned in commerce.

On Wednesday, July 13, 2016, a canadian trademark registration was filed for MEDAYLA by Sunovion Pharmaceuticals Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1791249. The current status of this trademark filing is Interruption of proceeding. The MEDAYLA trademark is filed in the description of Pharmaceutical preparations for treating central nervous system diseases or disorders , Pharmaceutical preparations for treating central nervous system diseases and disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking habits or addictions, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse or respiratory system diseases or disorders, Parkinson's Disease OFF (Hypomobility) episodes and binge eating disorders; pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; Pharmaceutical preparations for the treatment of Parkinson's Disease; Therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease , Pharmaceutical preparations for treating central nervous system diseases and disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking habits or addictions, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse or respiratory system diseases or disorders, Parkinson's Disease OFF (Hypomobility) episodes and binge eating disorders; pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; Pharmaceutical preparations for the treatment of Parkinson's Disease; Therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease , Pharmaceutical preparations for treating central nervous system diseases and disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking habits or addictions, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse or respiratory system diseases or disorders, Parkinson's Disease OFF (Hypomobility) episodes and binge eating disorders; pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; Pharmaceutical preparations for the treatment of Parkinson's Disease; Therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease .

Get FREE email alerts

100% Satisfaction Guarantee

protect your valuable brand now.

Classification Information

Class Code:	005 - Pharmaceutical Products
Description:	Pharmaceuticals and herbicides

Matter History Events

Status Date	Record Status Description
2019-10-23	Interruption of proceeding - Abandoned - Section 36
2019-09-11	National prosecution history entry - Agent Name Changed
2019-07-31	National prosecution history entry - Default Notice Sent
2018-04-27	National prosecution history entry - Allowed
2018-04-27	National prosecution history entry - Allowance Notice Sent
2018-01-10	Application published - Advertised
2017-12-21	Application accepted - Approved
2017-11-01	National prosecution history entry - Approval Notice Sent
2017-02-15	National prosecution history entry - Search Recorded
2017-02-15	National prosecution history entry - Examiner's First Report
2016-07-20	Filing date accorded - Formalized
2016-07-14	National prosecution history entry - Created
2016-07-13	Application filed - Filed

Word Mark:	MEDAYLA
Current Status:	Interruption of proceeding DEAD Mark! Start a New Filing Request 10/23/2019
Application Number:	1791249
Filing Date:	Wednesday, July 13, 2016
Filing Place:	Canada
Registration Date:	Not Available
Register Type:	Primary
Type Of Mark:	Trademark
Mark Feature:	Word
Use In Commerce:	No
Publication Registration:	Wednesday, January 10, 2018
Opposition:	1/10/2018 - 1/10/2018
Last Applicant/Owner:	SUNOVION PHARMACEUTICALS INC. ******* ****** * **
Correspondent:	Not provided

Goods and Services Information
Description:	(1) - Pharmaceutical preparations for treating central nervous system diseases or disorders (2) - Pharmaceutical preparations for treating central nervous system diseases and disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking habits or addictions, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse or respiratory system diseases or disorders, Parkinson's Disease OFF (Hypomobility) episodes and binge eating disorders; pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; Pharmaceutical preparations for the treatment of Parkinson's Disease; Therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease (3) - Pharmaceutical preparations for treating central nervous system diseases and disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking habits or addictions, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse or respiratory system diseases or disorders, Parkinson's Disease OFF (Hypomobility) episodes and binge eating disorders; pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; Pharmaceutical preparations for the treatment of Parkinson's Disease; Therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease (4) - Pharmaceutical preparations for treating central nervous system diseases and disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking habits or addictions, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse or respiratory system diseases or disorders, Parkinson's Disease OFF (Hypomobility) episodes and binge eating disorders; pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; Pharmaceutical preparations for the treatment of Parkinson's Disease; Therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease

Perfect for these industries

Words that describe this mark

a canadian trademark registration was filed for by . The Canadian IP office has given the trademark application number of . The current status of this trademark filing is . The correspondent listed for is The trademark is filed in the description of .

Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

100% Satisfaction Guarantee

protect your valuable brand now.

How it works

1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.

2. Describe how your business or product is being used. Register your mark in 180+ countries.

What you get

1. Top Global Specialist - Credibility and Experience!

2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK

How it works

1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.

2. Describe how your business or product is being used. Register your mark in 180+ countries.

What you get

1. Top Global Specialist - Credibility and Experience!

2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK

What You Can Do:

Start Your Business

Get FREE email alerts

Add to Favorites

Start Canada Trademark Filing

Custom Logo Design $99

Search on popular social networks

This mark may be available for re-registration. You can apply for it through Trademarkia at a low cost of $449!

Trademarkia.com will perform a final search in order to verify that this mark is available for Canada Trademark re-registration. All Trademarkia services are backed by a 100% satisfaction guarantee.

Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!

As seen on